Polivy and Pneumonia - a phase IV clinical study of FDA data

Summary:

Pneumonia is reported as a side effect among people who take Polivy (polatuzumab vedotin-piiq), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Pneumonia when taking Polivy. It is created by eHealthMe based on reports of 2,455 people who have side effects when taking Polivy from the FDA, and is updated regularly.

What is Polivy?

Polivy has active ingredients of polatuzumab vedotin-piiq. eHealthMe is studying from 2,455 Polivy users. Check the latest studies of Polivy.

What is Pneumonia?

Pneumonia is found to be associated with 3,353 drugs and 4,681 conditions by eHealthMe. Check the latest studies of Pneumonia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

2,455 people reported to have side effects when taking Polivy.
Among them, 50 people (2.04%) have Pneumonia.

Among these 50 people:

How long have people been on Polivy when they have Pneumonia? *

What is the gender of people who have Pneumonia when taking Polivy? *

female: 48.84 %
male: 51.16 %

What is the age of people who have Pneumonia when taking Polivy? *

What are other drugs people take besides Polivy? *

Cyclophosphamide: 26 people, 52.00%
Prednisolone: 12 people, 24.00%
Bendamustine Hydrochloride: 10 people, 20.00%
Dexamethasone: 9 people, 18.00%
Doxorubicin Hydrochloride: 8 people, 16.00%
Rituxan: 6 people, 12.00%
Bendamustine: 6 people, 12.00%
Prednisone: 5 people, 10.00%
Valtrex: 4 people, 8.00%
Carboplatin: 4 people, 8.00%

What are other side effects people have besides Pneumonia? *

Death: 9 people, 18.00%
Thrombocytopenia (decrease of platelets in blood): 8 people, 16.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 14.00%
Febrile Neutropenia (fever with reduced white blood cells): 7 people, 14.00%
Hepatic Failure (liver failure): 6 people, 12.00%
Myelosuppression (a decrease in the production of blood cells): 6 people, 12.00%
Acute Kidney Failure: 5 people, 10.00%
Neuropathy Peripheral (surface nerve damage): 4 people, 8.00%
Fever: 4 people, 8.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 8.00%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 32 people, 64.00%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 5 people, 10.00%
Diffuse Large B-Cell Lymphoma Stage Iii (cancer of b cells, a type of white blood cell-stage iii): 5 people, 10.00%
Lymphoma (cancer that begins in immune system cells): 4 people, 8.00%
Urinary Tract Infection: 1 person, 2.00%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.00%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 1 person, 2.00%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 2.00%
Immunodeficiency Common Variable: 1 person, 2.00%
Fungal Infection: 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Polivy and have Pneumonia?

- Check whether Pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Polivy:

Polivy (2,455 reports)

Pneumonia treatments and more:

Pneumonia (433,139 reports)

Browse all side effects of Polivy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia:

Pneumonia (3,353 drugs)

Browse all the conditions that are associated with Pneumonia:

Pneumonia (4,681 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polatuzumab vedotin-piiq (the active ingredients of Polivy) and Polivy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.